Practice Fusion launches real-time healthcare database Insight

SAN FRANCISCO — Practice Fusion on Wednesday launched its real-time healthcare database, Insight. With Insight, physicians, researchers and analysts can access analysis sourced from a de-identified subset of more than 81 million patient records. Insight users can explore health and pharmaceutical market trends, including diagnoses across patient populations, all in real-time.

Offered free of charge, Insight is designed to provide a full perspective across the healthcare spectrum, from diagnosis to treatment, that can identify new research opportunities and market trends.

“Real-time patient health data has been kept under lock and key, both because of technology limitations and the companies monetizing that data at a high cost—until today,” stated Ryan Howard, CEO Practice Fusion. “Insight unleashes powerful, de-identified health data from tens of millions of real patients and more than 2,000 drug therapies in real time, at no cost. This is a hugely disruptive move in the health data industry.”

Covering diagnoses from seasonal infections like influenza to such chronic conditions as diabetes, Insight enables users to explore data to uncover:

• The current and historical market share of prescription medications compared to other medications in that drug class;


• Currently trending diagnoses for a real-time view of current outbreaks;


• Diagnosis trends over time to uncover trends in seasonal infections;


• Proportion of patients with a diagnosis by body-mass index, age group or sex; and


• Top 100 diagnoses seen nationally on the Practice Fusion platform. 

Practice Fusion also offers a premium version of Insight for those looking for more in-depth, granular analyses. Features of the paid platform include:

• Additional data views including: patient profile, prescriber profile, Rx switching and treatment flow; filters allowing the selection of specific patient subpopulations; and the ability to see any data view for that specific subpopulation;


• Ability to view the market share of any prescription medication within a patient subpopulation; and


• Custom-curated reports offering real-time and in-depth performance analyses of any drug therapy in the outpatient market, available by request.